QNRX · Insider trading · 13F holders · Congress trades
Quoin Pharmaceuticals, Ltd. (QNRX)
Who is buying and selling QNRX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 4
- Insider buys, 90 days
- $280K
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
QNRX at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 4 QNRX insiders filed 4 open-market purchases worth $280K on SEC Form 4.
- 4 13F filers hold QNRX among their 50 largest positions, worth $2.5M combined. The biggest bets by portfolio weight are Dauntless Investment Group, LLC (1.8%), Stonepine Capital Management, LLC (0.7%) and Velan Capital Investment Management LP (0.1%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in QNRX.
- QNRX last closed at $4.15 on Oct 29, 2026.
QNRX insider trading
Between Aug 1, 2026 and Oct 29, 2026, 4 QNRX insiders filed 4 open-market purchases worth $280K on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Carter Denise P. | Chief Operating Officer, Director | Buy | 20,490 | $4.88 | $100K | SEC |
| Sep 1, 2026 | Myers Michael | Chief Executive Officer, Director | Buy | 20,490 | $4.88 | $100K | SEC |
| Sep 1, 2026 | Lawlor Sally Bridget | Chief Financial Officer | Buy | 10,244 | $4.88 | $50K | SEC |
| Sep 1, 2026 | Culverwell Anthony James | Director | Buy | 6,146 | $4.88 | $30K | SEC |
Who owns QNRX? Hedge funds and superinvestors
4 13F filers hold QNRX among their 50 largest positions, worth $2.5M combined. The biggest bets by portfolio weight are Dauntless Investment Group, LLC (1.8%), Stonepine Capital Management, LLC (0.7%) and Velan Capital Investment Management LP (0.1%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLCInvestment manager | 1.8% | $1.0M | 214,987 | +9.4% shares | Q2 2026 |
| Stonepine Capital Management, LLCHedge fund | 0.7% | $966K | 199,486 | +273.2% shares | Q2 2026 |
| AIGH Capital Management LLCHedge fund | 0.0% | $339K | 70,000 | +37.3% shares | Q2 2026 |
| Velan Capital Investment Management LPHedge fund | 0.1% | $157K | 32,372 | -61.8% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 4). Screen QNRX in the grand portfolio →
QNRX stock trades by members of Congress
No member of Congress has disclosed a trade in QNRX.
QNRX questions and answers
Are insiders buying QNRX stock?
Between Aug 1, 2026 and Oct 29, 2026, 4 QNRX insiders filed 4 open-market purchases worth $280K on SEC Form 4.
Which hedge funds own QNRX?
4 13F filers hold QNRX among their 50 largest positions, worth $2.5M combined. The biggest bets by portfolio weight are Dauntless Investment Group, LLC (1.8%), Stonepine Capital Management, LLC (0.7%) and Velan Capital Investment Management LP (0.1%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
Has Congress traded QNRX?
No member of Congress has disclosed a trade in QNRX.
Who is the largest holder of QNRX?
Among 13F filers, Dauntless Investment Group, LLC reports the largest QNRX position, $1.0M (214,987 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Dauntless Investment Group, LLC's: 1.8% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.